NF-IL6 (C/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G. 2008

Shigemi M Kinoshita, and Shizuka Taguchi
Laboratory of Combined Research on Microbiology and Immunology, Research Institute of Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. shigemik@biken.osaka-u.ac.jp

T cell activation is crucial for the productive HIV-1 infection of primary T cells; however, little is known about the host molecules involved in this process. We show that the host transcription factor NF-IL6 (also called C/EBPbeta) renders primary CD4(+) T cells highly permissive for HIV-1 replication. NF-IL6 facilitates reverse transcription of the virus by binding to and inhibiting the antiviral cytidine deaminase APOBEC3G. A mutation in NF-IL6 at Ser-288 weakened its binding to APOBEC3G and strongly inhibited HIV-1 replication. NF-IL6 also induced the replication of a Vif-deficient strain of HIV-1 in nonpermissive HUT78 cells. These data indicate that NF-IL6 is a natural inhibitor of APOBEC3G that facilitates HIV-1 replication. Host factors, such as NF-IL6, that are involved in early HIV-1 replication are potential targets for anti-HIV-1 therapy. Our findings shed light on the activation of HIV-1 replication by T cell host molecules and reveal a unique regulation of DNA deamination by APOBEC3G and NF-IL6.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071480 APOBEC-3G Deaminase An APOBEC deaminase that functions as an inhibitor of RETROVIRIDAE replication and inhibits the mobility of RETROTRANSPOSONS via deaminase-dependent and independent mechanisms. It is selective for SINGLE-STRANDED DNA and does not deaminate double-stranded DNA or single or DOUBLE-STRANDED RNA. It exhibits potent antiviral activity against VIF PROTEIN deficient HIV-1 through the creation of hypermutations in the VIRAL DNA. It also has anti-viral activity against SIMIAN IMMUNODEFICIENCY VIRUSES and HEPATITIS B VIRUS. APOBEC-3G Protein,APOBEC-3G dC-dU Editing Enzyme,APOBEC-Related Cytidine Deaminase,APOBEC-Related Protein,APOBEC3G Deaminase,APOBEC3G Protein,CEM15 Protein,APOBEC 3G Deaminase,APOBEC 3G Protein,APOBEC 3G dC dU Editing Enzyme,APOBEC Related Cytidine Deaminase,APOBEC Related Protein,Cytidine Deaminase, APOBEC-Related,Deaminase, APOBEC-3G,Deaminase, APOBEC3G
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D022782 CCAAT-Enhancer-Binding Protein-beta A CCAAT-enhancer-binding protein found in LIVER; INTESTINES; LUNG and ADIPOSE TISSUE. It is an important mediator of INTERLEUKIN-6 signaling. C-EBP-beta,NF-IL6,23-C-EBP Protein,40-C-EBP Protein,AGP-EBP Transcription Factor,C-EBP beta,C-EBP-Related Protein 2,C-EBPbeta,CRP2 Protein,IL-6 DBP,IL-6-Dependent DNA Binding Protein,Interleukin-6 Nuclear Factor,LAP Transcription Factor,Liver-Enriched Inhibiting Protein,Liver-Enriched Inhibitory Protein, LIP,2, C-EBP-Related Protein,AGP EBP Transcription Factor,C EBP Related Protein 2,C EBP beta,C EBPbeta,CCAAT Enhancer Binding Protein beta,IL 6 Dependent DNA Binding Protein,Inhibiting Protein, Liver-Enriched,Interleukin 6 Nuclear Factor,Liver Enriched Inhibiting Protein,Liver Enriched Inhibitory Protein, LIP,Nuclear Factor, Interleukin-6,Protein-beta, CCAAT-Enhancer-Binding,Transcription Factor, AGP-EBP,Transcription Factor, LAP

Related Publications

Shigemi M Kinoshita, and Shizuka Taguchi
May 2009, Virology,
Shigemi M Kinoshita, and Shizuka Taguchi
May 2007, Microbes and infection,
Shigemi M Kinoshita, and Shizuka Taguchi
April 2008, The Journal of biological chemistry,
Shigemi M Kinoshita, and Shizuka Taguchi
October 2008, Nature structural & molecular biology,
Shigemi M Kinoshita, and Shizuka Taguchi
January 2005, Nature,
Shigemi M Kinoshita, and Shizuka Taguchi
May 2009, Virology,
Shigemi M Kinoshita, and Shizuka Taguchi
January 2007, Nucleic acids research,
Shigemi M Kinoshita, and Shizuka Taguchi
September 2017, Nature communications,
Shigemi M Kinoshita, and Shizuka Taguchi
July 2003, Nature,
Shigemi M Kinoshita, and Shizuka Taguchi
July 2000, The Journal of biological chemistry,
Copied contents to your clipboard!